Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026 Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (“AI”)

#MDAI #MDAIW Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026

www.stocktitan.net/news/MDAI/spectral-ai-an...

$31.7M backs AI imaging tool aimed at faster burn care decisions The non-dilutive award adds to $54.9M already committed under a BARDA contract worth up to $150M as DeepView awaits FDA market authorization.

#MDAI #MDAIW Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System

www.stocktitan.net/news/MDAI/spectral-ai-aw...

Spectral AI Schedules 2025 Fourth Quarter and Full Year Financial Results and Conference Call Spectral AI (Nasdaq: MDAI) will report fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026 after market close. A conference call to discuss results will be held the same day at 5:00 PM ET. Investors may dial in or join a simultaneous webcast via the company investor events page.Dial-in: 833-890-6620 (U.S.), 412-564-3789 (International). Webcast available at the company’s Investor Relations Events page.

#MDAI #MDAIW Spectral AI Schedules 2025 Fourth Quarter and Full Year Financial Results and Conference Call

www.stocktitan.net/news/MDAI/spectral-ai-sc...

#MDAI: In the Blocks, Ready to Go upon Mid-Year Authorization buff.ly/BOub2qR

#MDAI #MDAIW DeepView™ System Featured at 2025 US Burn Conferences

www.stocktitan.net/news/MDAI/deep-view-tm-s...

#MDAI: Looking Ahead to 1H:26 DeepView Clearance buff.ly/2WJ6x22

Spectral AI Announces 2025 Third Quarter Financial Results Spectral AI (NASDAQ: MDAI) reported third-quarter 2025 results for the period ended September 30, 2025, highlighting Q3 R&D revenue of $3.8 million and YTD revenue of $15.6 million. Cash improved to $10.5 million as of Sept 30, 2025 (flat vs Q2 2025; up from $3.7M in Q3 2024). The company recorded a Q3 net loss of $3.6 million versus $1.5 million a year earlier, driven by a 54% decline in R&D revenue after its June De Novo submission to the FDA.After quarter close (Oct 22, 2025) Spectral entered a securities purchase agreement raising ~$7.6 million gross via common shares, warrants and pre-funded warrants. Full-year revenue guidance was lowered from $21.5M to $18.5M, citing BARDA timing and a U.S. government shutdown impact.

#MDAI #MDAIW Spectral AI Announces 2025 Third Quarter Financial Results

www.stocktitan.net/news/MDAI/spectral-ai-an...

Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results

#MDAI #MDAIW Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call

www.stocktitan.net/news/MDAI/spectral-ai-sc...

Spectral AI raises $7.6 Million of Additional Growth Capital Spectral AI (Nasdaq: MDAI) priced a $7.6 million offering on October 23, 2025 to fund expansion of its DeepView® System. The financing includes the issuance of 4,000,000 shares of common stock and pre-funded warrants at $1.90 per share, plus corresponding warrants with an exercise price of $2.51 per share.The company said proceeds will support continued development, broaden clinical indications, and prepare for commercial readiness in 2026, while maintaining support for its BARDA Project BioShield contract. Northland Capital Markets served as exclusive placement agent and Reed Smith served as counsel.

#MDAI #MDAIW Spectral AI raises $7.6 Million of Additional Growth Capital

www.stocktitan.net/news/MDAI/spectral-ai-ra...

#MDAI: Second Quarter Results buff.ly/ve1gPGl

Spectral AI Announces 2025 Second Quarter Financial Results Spectral AI (NASDAQ:MDAI), an AI medical diagnostics company focused on wound care, reported its Q2 2025 financial results. The company achieved $5.1 million in R&D revenue for Q2 and $11.8 million for H1 2025. A significant milestone was reached with the completion of their De Novo FDA application submission for the DeepView System in June 2025.Financial highlights include a cash position of $10.5 million, up from $5.2 million in December 2024, supported by a $15 million debt financing agreement with Avenue Capital Group. The company reported a Q2 net loss of $7.9 million, primarily due to warrant liability adjustments. Gross margin was 45.2%, slightly down from 46.6% in Q2 2024. Management reaffirmed full-year 2025 revenue guidance of $21.5 million.

#MDAI #MDAIW Spectral AI Announces 2025 Second Quarter Financial Results

www.stocktitan.net/news/MDAI/spectral-ai-an...

Medical AI Pioneer Spectral AI Sets Q2 Earnings Date: What to Know About This Healthcare Tech Innovator AI-powered wound care diagnostics company announces Q2 2025 results on August 12. Learn about DeepView System's impact on medical decisions. Join the call.

#MDAI #MDAIW Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call

www.stocktitan.net/news/MDAI/spectral-ai-sc...

Senior Equity Analyst @vanjohn10.bsky.social highlights four companies' new product applications with the FDA: youtu.be/Ha0u0n87afc?...

#ACHV #GRCE #CING #MDAI

#MDAI: DeepView De Novo Submission buff.ly/QP1i6SW

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Most searched small-cap stocks, Tue Jul 1st - #WETO #ATAI #YYAS #VVOS #VLRS #RUN #RXRX #PL #MNDJF #MDAI #LEU #EOSE #CYN #APLD #BTCS #AEVA #BMNR #ACHC #BGLC - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Revolutionary AI System Predicts Burn Healing on Day One: Spectral AI Seeks FDA Approval AI-powered DeepView System enables same-day burn healing predictions, potentially transforming emergency burn care. First-of-its-kind technology awaits FDA review. Learn more.

#MDAI #MDAIW Spectral AI Announces Submission to FDA of its DeepView® System

www.stocktitan.net/news/MDAI/spectral-ai-an...

Revolutionary AI Burns Detection Technology Outperforms Human Doctors by 28% in UK Clinical Trial New clinical data reveals AI-powered DeepView system increases burn wound detection accuracy from 61% to 89%. See how this breakthrough transforms patient care.

#MDAI #MDAIW DeepView® System highlighted at the annual British Burn Association conference

www.stocktitan.net/news/MDAI/deep-view-syst...

Spectral AI Annual Meeting: 61% Shareholders Back New Board, Confirm KPMG as Auditor Strong 60.8% shareholder turnout elects six directors and approves KPMG as auditor for AI-powered medical diagnostics leader. See full voting details.

#MDAI #MDAIW Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders

www.stocktitan.net/news/MDAI/spectral-ai-an...

Revolutionary AI System Shows 95.3% Accuracy in Multi-Center Burn Assessment Study New clinical data reveals AI-powered DeepView System's exceptional accuracy in burn healing prediction. Published in Burns journal. See complete study results.

#MDAI #MDAIW DeepView® System Achieves 95.3% Accuracy Evaluation as Published in Burns Journal

www.stocktitan.net/news/MDAI/deep-view-syst...

#MDAI: 1Q:25 Results buff.ly/qcP2blK

Spectral AI Announces 2025 First Quarter Financial Results Spectral AI (NASDAQ: MDAI) reported its Q1 2025 financial results, highlighting R&D revenue of $6.7 million, up 6.0% from Q1 2024, and improved cash position of $14.1 million. The company achieved net income of $2.9 million, compared to a $3.2 million loss in Q1 2024. Key developments include completing a $15 million debt financing agreement with Avenue Capital Group (initial draw of $8.5 million) and raising $2.7 million in equity financing. The company completed its Burn Validation Study in March 2025, involving 164 patients, demonstrating superior performance of its DeepView System compared to clinical judgment. Spectral AI maintains its FY2025 revenue guidance of $21.5 million and plans FDA De Novo submission in H1 2025.

#MDAI #MDAIW Spectral AI Announces 2025 First Quarter Financial Results

www.stocktitan.net/news/MDAI/spectral-ai-an...

Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView ® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced that it will report financial

#MDAI #MDAIW Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

www.stocktitan.net/news/MDAI/spectral-ai-sc...

Burn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meeting Spectral AI (NASDAQ: MDAI) showcased its DeepView® System at the American Burn Association annual meeting in Phoenix, Arizona. The event, attended by over 2,200 burn care professionals, highlighted significant achievements in burn wound assessment technology. Key findings presented by Leslie Tan of Newcastle Burns Centre revealed the DeepView System's impressive 95% accuracy rate in predicting burn wound healing potential within 21 days. The technology received additional recognition when Zeeshan Sheikh of Wythenshawe Hospital won Best in Category for his presentation on patient experience with AI-Enhanced Multispectral Imaging. The DeepView System, which combines multi-spectral imaging with AI algorithms, is currently operational in several NHS hospitals in the United Kingdom. Newcastle Burn Centre, treating approximately 500 burn patients annually, became the first institution globally to conduct an independent evaluation of this technology.

#MDAI #MDAIW Burn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meeting

www.stocktitan.net/news/MDAI/burn-clinician...

#MDAI: 2024 Results buff.ly/oRA1YHU

Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results Spectral AI (NASDAQ: MDAI) reported its Q4 and full-year 2024 financial results, highlighting significant achievements in its AI-driven wound care diagnostics business. The company's research and development revenue reached $30 million in 2024, marking a 63.5% increase from 2023, primarily driven by their BARDA PBS contract.Key financial metrics include Q4 2024 R&D revenue of $7.6 million and a gross margin of 44.0%. The company reported a full-year net loss of $15.3 million. As of December 31, 2024, cash stood at $5.2 million, with additional Q1 2025 financing of $11.2 million through debt and equity.Notable achievements include successful results from the US Burn Validation Study, where their DeepView System demonstrated 86.6% sensitivity in identifying non-healing tissue, significantly outperforming burn physicians' 40.8%. The company plans FDA submission in Q2 2025 and anticipates first commercial revenue in H2 2025.

#MDAI #MDAIW Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

www.stocktitan.net/news/MDAI/spectral-ai-an...

NEWS: ( NASDAQ: #MDAI ) Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization

Spectral AI Lands Major $15M Funding for Revolutionary AI-Powered Burn Assessment Technology AI medical innovator strengthens position with $8.5M initial draw plus equity raise, advancing DeepView System's U.S. launch. See commercialization timeline inside.

#MDAI #MDAIW Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization

www.stocktitan.net/news/MDAI/spectral-ai-ra...

#MDAI: Burn Study Topline Data buff.ly/QJlPCrb

Revolutionary AI System Shows 86% Accuracy in Burn Assessment, Doubles Physician Performance Spectral AI's DeepView system achieves 86.6% sensitivity in groundbreaking burn healing prediction study. FDA submission planned for Q2 2025 with potential 2026 approval.

#MDAI #MDAIW Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System

www.stocktitan.net/news/MDAI/spectral-ai-an...

Revolutionary AI Burn Assessment Technology Launches in Australia's Leading Hospitals - What Makes It Different? AI-powered burn assessment technology expands to three premier Australian hospitals, advancing global deployment of FDA Breakthrough-designated DeepView System.

#MDAI #MDAIW Spectral AI Completes Three Device Installations in Australia

www.stocktitan.net/news/MDAI/spectral-ai-co...